Use of C1 inhibitor for the prevention of ischemia-reperfusion injury

Details for Australian Patent Application No. 2006327989 (hide)

Owner Pharming Intellectual Property BV

Inventors De Simoni, Maria Grazia; Mannesse, Maurice; Pieper, Frank; Ziere, Gijsbertus Johannes; Nuijens, Johannes Henricus

Agent Griffith Hack

Pub. Number AU-B-2006327989

PCT Pub. Number WO2007/073186

Priority 60/760,944 23.01.06 US; 05112630.8 21.12.05 EP

Filing date 19 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 7 June 2012

International Classifications

A61K 38/57 (2006.01) Medicinal preparations containing peptides

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/073186 Priority application(s): WO2007/073186

7 June 2012 Application Accepted

  Published as AU-B-2006327989

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006327990-Carbohydrate composition for flat glucose response

2006327982-Diagnostic methods involving determining gene copy numbers and SNPs in the FcgammaRII/FcgammRIII gene cluster, and probes for use in such methods to detect susceptibility to and treatment efficacy in autoimmune diseases